198 related articles for article (PubMed ID: 1322570)
1. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Nawa K; Itani T; Ono M; Sakano K; Marumoto Y; Iwamoto M
Thromb Haemost; 1992 Mar; 67(3):366-70. PubMed ID: 1322570
[TBL] [Abstract][Full Text] [Related]
2. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effects of recombinant human soluble thrombomodulin in a rat model of vascular shunt thrombosis.
Ono M; Nawa K; Marumoto Y
Thromb Haemost; 1994 Sep; 72(3):421-5. PubMed ID: 7855794
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
5. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
[TBL] [Abstract][Full Text] [Related]
6. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
Marbet GA; Griffith MJ; Roberts HR
Scand J Clin Lab Invest Suppl; 1985; 178():95-8. PubMed ID: 3867125
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP
Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120
[TBL] [Abstract][Full Text] [Related]
8. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
[TBL] [Abstract][Full Text] [Related]
10. Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats.
Mohri M; Oka M; Aoki Y; Gonda Y; Hirata S; Gomi K; Kiyota T; Sugihara T; Yamamoto S; Ishida T
Am J Hematol; 1994 Apr; 45(4):298-303. PubMed ID: 8178801
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
12. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
Marbet GA; Griffith MJ
Thromb Haemost; 1986 Feb; 55(1):78-85. PubMed ID: 3518133
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human antithrombin expressed in Chinese hamster ovary cells shows in vivo efficacy on rat DIC model similarly to plasma-derived antithrombin regardless of different N-glycosylation.
Hirose M; Tsukada M; Hirayama F; Kubo Y; Kajii M; Mochizuki S; Hamato N; Ohi H
Thromb Res; 2007; 119(5):631-41. PubMed ID: 16844203
[TBL] [Abstract][Full Text] [Related]
15. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
Yun-Choi HS; Pyo MK; Chang KC; Lee DH
Planta Med; 2002 Apr; 68(4):326-9. PubMed ID: 11988856
[TBL] [Abstract][Full Text] [Related]
16. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
18. [Antithrombotic effect of recombinant human thrombomodulin on experimentally induced thrombosis in rats].
Shinmyozu K; Maruyama I
Rinsho Ketsueki; 1991 May; 32(5):497-503. PubMed ID: 1651429
[TBL] [Abstract][Full Text] [Related]
19. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
20. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]